# Safety and Tolerability of Nitro for Radial Artery Dilation

> **NCT05239013** · EARLY_PHASE1 · UNKNOWN · sponsor: **Thomas Jefferson University** · enrollment: 20 (estimated)

## Conditions studied

- Artery; Dilatation

## Interventions

- **DRUG:** Nitroglycerin ointment

## Key facts

- **NCT ID:** NCT05239013
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-01
- **Primary completion:** 2023-03-01
- **Final completion:** 2023-03-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05239013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05239013, "Safety and Tolerability of Nitro for Radial Artery Dilation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05239013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*